Detalles de la búsqueda
1.
Polypharmacy and Bleeding Outcomes After Percutaneous Coronary Intervention.
Circ J
; 2023 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37722886
2.
Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japanã- From the CREDO-Kyoto Registry Cohort-2 and Cohort-3.
Circ J
; 86(5): 748-759, 2022 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34526432
3.
Concomitant Mitral Regurgitation in Severe Aortic Stenosisã- A Report From the CURRENT AS Registry.
Circ J
; 86(3): 427-437, 2022 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34275976
4.
Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Interventionã- From the CREDO-Kyoto Registry Cohort-3.
Circ J
; 85(6): 769-781, 2021 05 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33298644
5.
Cardiac Tamponade and Duodenal Hemorrhage Caused by Inappropriate Use of Dabigatran in a Patient With End-Stage Renal Failure: A Case Report.
Cureus
; 16(1): e52521, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38371033
6.
Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization; a report from the CREDO-Kyoto registry.
J Cardiol
; 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38871119
7.
Life Expectancy of Patients With Severe Aortic Stenosis in Relation to Age and Surgical Risk Score.
Ann Thorac Surg
; 116(6): 1195-1203, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36739072
8.
Ischemic and Bleeding Events After First Major Bleeding Event in Patients Undergoing Coronary Stent Implantation.
Am J Cardiol
; 162: 13-23, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34706818
9.
Coronary Artery Disease Without Standard Cardiovascular Risk Factors.
Am J Cardiol
; 164: 34-43, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34852931
10.
Modifiers of the Risk of Diabetes for Long-Term Outcomes After Coronary Revascularization: CREDO-Kyoto PCI/CABG Registry.
JACC Asia
; 2(3): 294-308, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36411876
11.
Percutaneous coronary intervention using new-generation drug-eluting stents versus coronary arterial bypass grafting in stable patients with multi-vessel coronary artery disease: From the CREDO-Kyoto PCI/CABG registry Cohort-3.
PLoS One
; 17(9): e0267906, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36174029
12.
Effect of Polypharmacy on Long-Term Mortality After Percutaneous Coronary Intervention.
Am J Cardiol
; 159: 19-29, 2021 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34497005
13.
Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3).
Am J Cardiol
; 145: 25-36, 2021 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33454340
14.
Coronary Revascularization in the Past Two Decades in Japan (From the CREDO-Kyoto PCI/CABG Registries Cohort-1, -2, and -3).
Am J Cardiol
; 153: 20-29, 2021 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34238444
15.
[Abnormal bone marrow uptake of 99mTc-tetrofosmin in myelodysplastic syndrome with ineffective hematopoiesis: a case report].
Kaku Igaku
; 45(1): 9-12, 2008 Feb.
Artículo
en Japonés
| MEDLINE | ID: mdl-19594095
16.
A Gerbode defect complicated by pulmonary embolism: a rare case evaluated by cardiac computed tomography.
Eur Heart J Case Rep
; 7(1): ytad001, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36685098
17.
The ReACT Trial: Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial.
JACC Cardiovasc Interv
; 10(2): 109-117, 2017 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28040445
18.
Clinical efficacy of thrombus aspiration on 5-year clinical outcomes in patients with ST-segment elevation acute myocardial infarction undergoing percutaneous coronary intervention.
J Am Heart Assoc
; 4(6): e001962, 2015 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26077588
19.
Antiplatelet therapy discontinuation and the risk of serious cardiovascular events after coronary stenting: observations from the CREDO-Kyoto Registry Cohort-2.
PLoS One
; 10(4): e0124314, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25853836
20.
Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2.
Circ Cardiovasc Interv
; 7(2): 168-79, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24550439